2017
DOI: 10.3389/fnbeh.2016.00248
|View full text |Cite
|
Sign up to set email alerts
|

Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity

Abstract: Recent studies have used conditional knockout mice to selectively delete the D2 autoreceptor; however, these approaches result in global deletion of D2 autoreceptors early in development. The present study takes a different approach using RNA interference (RNAi) to knockdown the expression of the D2 receptors (D2R) in the substantia nigra (SN), including dopaminergic neurons, which project primarily to the dorsal striatum (dStr) in adult rats. This approach restricts the knockdown primarily to nigrostriatal pa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
15
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(17 citation statements)
references
References 43 publications
(56 reference statements)
1
15
1
Order By: Relevance
“…We found a general decrease in DA release that was partially rescued in the presence of a DAT antagonist. Our finding of a decrease in evoked DA overflow, although somewhat counter-intuitive when considering the autoreceptor function of the D2 receptor, is in line with previous observations of constitutive or conditional D2R KO mice [4347] (but see [48]). While we found here that this reduced DA release could be rescued by nomifensine, in a previous study, the use of a DAT antagonist was not sufficient to return DA levels to normal in the engrailed1-based D2-cKO [44].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…We found a general decrease in DA release that was partially rescued in the presence of a DAT antagonist. Our finding of a decrease in evoked DA overflow, although somewhat counter-intuitive when considering the autoreceptor function of the D2 receptor, is in line with previous observations of constitutive or conditional D2R KO mice [4347] (but see [48]). While we found here that this reduced DA release could be rescued by nomifensine, in a previous study, the use of a DAT antagonist was not sufficient to return DA levels to normal in the engrailed1-based D2-cKO [44].…”
Section: Discussionsupporting
confidence: 90%
“…We also did not detect a significant change in DAT surface levels using a DAT surface biotinylation assay. However, a reduction in Vmax has been observed in a previous study in which the D2 receptor was knocked down acutely using siRNA [47], although reuptake kinetics (tau) were not reported. The difference with our data could be explained by the acute nature of the deletion in this previous study.…”
Section: Discussionmentioning
confidence: 97%
“…Although there is no question that D2 autoreceptor activity critically regulates DA neuron activity, a downregulation of astrocytic D2Rs by chronic drug exposure may also be partly responsible for drug-induced plasticity in the ventral midbrain. Similarly, enhancing or dampening astrocytic D2Rs may partly account for the effects of D2R-targeted drugs or genetic manipulation of D2R expession on drug-seeking behavior [6770]. With the development of new, selective astrocyte mouse lines [71], future studies will be able to define the relative contribution of astrocytic and DA neuron D2Rs to drug-related plasticity and behaviors.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, studies that examined DA uptake following targeted genetic manipulation of D2 autoreceptors in DA neurons have produced conflicting results (Anzalone et al, 2012; Bello et al, 2011; Budygin et al, 2016). Consequently, it is not surprising that in the current studies heightened D2 autoreceptor sensitivity observed in resilient subjects did not correspond with alterations in DA uptake.…”
Section: 0 Discussionmentioning
confidence: 99%